Cargando…
Decreased circulating Zinc levels in Parkinson’s disease: a meta-analysis study
There is no consensus on the involvement of zinc (Zn) dysfunctions in Parkinson’s Disease (PD). We performed a meta-analysis to evaluate whether circulating Zn levels in the serum, plasma, and cerebrospinal fluid (CSF) are altered in PD. Twenty-three published studies were selected by searching the...
Autores principales: | Du, Ke, Liu, Ming-Yan, Zhong, Xin, Wei, Min-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478669/ https://www.ncbi.nlm.nih.gov/pubmed/28634347 http://dx.doi.org/10.1038/s41598-017-04252-0 |
Ejemplares similares
-
Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis
por: Jin, Xin, et al.
Publicado: (2018) -
Association of Circulating Apolipoprotein AI Levels in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Tong, Jun-hui, et al.
Publicado: (2022) -
Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
por: Zhong, Xin, et al.
Publicado: (2017) -
Assessing Plasma Levels of Selenium, Copper, Iron and Zinc in Patients of Parkinson’s Disease
por: Zhao, Hai-Wen, et al.
Publicado: (2013) -
Association of Circulating Magnesium Levels in Patients With Alzheimer's Disease From 1991 to 2021: A Systematic Review and Meta-Analysis
por: Du, Ke, et al.
Publicado: (2022)